In this case, cancer prevention with vitamin D could turn out as a viable alternative to COX-2 inhibition by non-steroidal anti-inflammatory drugs, because 1,25-(OH)2D3 has the potential to inhibit COX-2 [33] and to protect from adverse cardiovascular events [36]. This evidence concerns the gene PTGS2 and cancer.